Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
These highlights do not include all the information needed to use BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES safely and effectively. See full prescribing information for BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE CAPSULES. BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, and TETRACYCLINE HYDROCHLORIDE capsules, for oral useInitial U.S. Approval: 2006
4c7f024d-ba26-43cf-a36f-597e2168cd9f
HUMAN PRESCRIPTION DRUG LABEL
Dec 13, 2022
Ingenus Pharmaceuticals, LLC
DUNS: 833250017
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride
Product Details
FDA regulatory identification and product classification information